Hemostemix Inc.
HEM.V
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.47M | -1.43M | -1.26M | -1.85M | -2.34M |
| Total Depreciation and Amortization | 0.00 | 0.00 | 0.00 | 0.00 | 100.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 377.80K | 450.90K | 394.70K | 391.80K | 683.50K |
| Change in Net Operating Assets | 842.00K | 710.40K | 249.90K | 407.10K | 136.80K |
| Cash from Operations | -245.50K | -265.20K | -614.50K | -1.05M | -1.52M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -100.00K | 0.00 | 0.00 |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 18.30K | 338.80K | 742.30K | 1.52M | 1.50M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -31.10K | -50.90K | -78.10K | -78.10K |
| Cash from Financing | 13.50K | 229.30K | 440.50K | 1.07M | 1.05M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -232.00K | -35.90K | -174.00K | 16.30K | -465.80K |